Related Experiment Videos
Bone marrow transplantation in a child with acute lymphoblastic leukaemia
Insights
This study details a successful bone marrow transplant for acute lymphoblastic leukemia. The patient achieved remission with minimal graft versus host disease, managed effectively by prednisone.
Area of Science:
- Hematology
- Immunology
- Pediatric Oncology
Background:
- Acute lymphoblastic leukemia (ALL) is a common childhood cancer.
- Bone marrow transplantation (BMT) is a potential curative therapy for ALL.
- Graft versus host disease (GVHD) is a significant complication following allogeneic BMT.
Observation:
- A pediatric patient with ALL in second remission underwent allogeneic BMT from a HLA-compatible sibling.
- Engraftment was confirmed 14 days post-transplantation.
- The patient presented with mild, transient skin rash and hepatocellular disturbance, indicative of GVHD.
Findings:
- The patient achieved complete hematological remission 171 days post-BMT.
- GVHD manifestations were successfully managed with high-dose prednisone.
- The BMT procedure was clinically successful in achieving long-term remission.
Implications:
- Allogeneic BMT is an effective treatment for pediatric ALL, even in advanced stages.
- Early recognition and management of GVHD are crucial for favorable outcomes.
- Prednisone is an effective therapeutic agent for managing mild GVHD post-BMT.
Abstract:
A caucasian female infant with acute lymphoblastic leukaemia in second remission received a bone marrow transplantation. Engraftment was confirmed at 14 days following infusion of bone marrow from a sex-matched, ABO and HLA compatible sibling. 171 days posttransplantation the patient is clinically well and in haematological remission. A mild transient skin rash and hepatocellular disturbance, the only manifestations of graft versus host disease, responded successfully to high dose prednisone.